NCT00283478View on ClinicalTrials.gov

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

April 30, 2007

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Iscar Quercus

DRUG

Gemcitabine

Trial Locations (1)

40202

Kentuckiana Cancer Institute, Louisville

All Listed Sponsors
lead

Kentuckiana Cancer Institute

OTHER

NCT00283478 - Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter